

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.01657635 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.01657635 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 4.66664308 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 4.66664308 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.66664308 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.66664308 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.66664308 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.66664308 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.47625189 |
| 10 | microglial cell activation (GO:0001774) | 4.45754295 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.37986111 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.33472118 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.18769555 |
| 14 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.04045528 |
| 15 | negative regulation of interleukin-12 production (GO:0032695) | 3.79663975 |
| 16 | positive regulation of mast cell activation (GO:0033005) | 3.78114592 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 3.76759190 |
| 18 | positive thymic T cell selection (GO:0045059) | 3.69941704 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 3.68137569 |
| 20 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.63862322 |
| 21 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.62089240 |
| 22 | positive regulation of macrophage differentiation (GO:0045651) | 3.55412701 |
| 23 | positive T cell selection (GO:0043368) | 3.51948064 |
| 24 | regulation of T cell tolerance induction (GO:0002664) | 3.51578211 |
| 25 | regulation of mast cell degranulation (GO:0043304) | 3.44176419 |
| 26 | mast cell activation (GO:0045576) | 3.40709533 |
| 27 | regulation of mast cell activation (GO:0033003) | 3.39784325 |
| 28 | detection of other organism (GO:0098543) | 3.36748116 |
| 29 | negative T cell selection (GO:0043383) | 3.36000274 |
| 30 | positive regulation of mast cell degranulation (GO:0043306) | 3.33693662 |
| 31 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.33693662 |
| 32 | adenosine receptor signaling pathway (GO:0001973) | 3.31815466 |
| 33 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.25780448 |
| 34 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.24795744 |
| 35 | negative regulation of bone resorption (GO:0045779) | 3.24193418 |
| 36 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.21851467 |
| 37 | regulation of platelet activation (GO:0010543) | 3.21008630 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 3.20248291 |
| 39 | negative regulation of interleukin-17 production (GO:0032700) | 3.20140769 |
| 40 | detection of molecule of bacterial origin (GO:0032490) | 3.19467904 |
| 41 | negative regulation of granulocyte differentiation (GO:0030853) | 3.18426266 |
| 42 | regulation of platelet aggregation (GO:0090330) | 3.18055373 |
| 43 | myeloid cell activation involved in immune response (GO:0002275) | 3.17858473 |
| 44 | B cell mediated immunity (GO:0019724) | 3.17844773 |
| 45 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.16530419 |
| 46 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.12260207 |
| 47 | response to host immune response (GO:0052572) | 3.12242519 |
| 48 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.12242519 |
| 49 | detection of bacterium (GO:0016045) | 3.11943394 |
| 50 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.11697313 |
| 51 | macrophage activation (GO:0042116) | 3.10190864 |
| 52 | negative thymic T cell selection (GO:0045060) | 3.10076463 |
| 53 | positive regulation of B cell differentiation (GO:0045579) | 3.09593123 |
| 54 | detection of external biotic stimulus (GO:0098581) | 3.07540696 |
| 55 | neurofilament cytoskeleton organization (GO:0060052) | 3.04105232 |
| 56 | pinocytosis (GO:0006907) | 3.02400290 |
| 57 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.02344871 |
| 58 | regulation of B cell differentiation (GO:0045577) | 3.01925958 |
| 59 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.00351225 |
| 60 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.98985568 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 2.97346287 |
| 62 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93054109 |
| 63 | response to acidic pH (GO:0010447) | 2.91203394 |
| 64 | germinal center formation (GO:0002467) | 2.91057783 |
| 65 | T cell migration (GO:0072678) | 2.90904625 |
| 66 | response to host (GO:0075136) | 2.90506021 |
| 67 | response to host defenses (GO:0052200) | 2.90506021 |
| 68 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.90506021 |
| 69 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.90314312 |
| 70 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.90314312 |
| 71 | regulation of hypersensitivity (GO:0002883) | 2.88607330 |
| 72 | interferon-gamma production (GO:0032609) | 2.86879208 |
| 73 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.86419401 |
| 74 | leukocyte aggregation (GO:0070486) | 2.85740541 |
| 75 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.84535675 |
| 76 | purinergic receptor signaling pathway (GO:0035587) | 2.83033931 |
| 77 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.81173455 |
| 78 | regulation of leukocyte degranulation (GO:0043300) | 2.80924659 |
| 79 | positive regulation of interferon-alpha production (GO:0032727) | 2.80666087 |
| 80 | negative regulation of mast cell activation (GO:0033004) | 2.79760618 |
| 81 | cellular extravasation (GO:0045123) | 2.79315762 |
| 82 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.78899310 |
| 83 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.78276932 |
| 84 | activated T cell proliferation (GO:0050798) | 2.77292390 |
| 85 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.76189300 |
| 86 | B cell receptor signaling pathway (GO:0050853) | 2.76134446 |
| 87 | detection of temperature stimulus (GO:0016048) | 2.74782451 |
| 88 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.73671394 |
| 89 | phagocytosis, engulfment (GO:0006911) | 2.72123540 |
| 90 | regulation of regulatory T cell differentiation (GO:0045589) | 2.71717373 |
| 91 | detection of biotic stimulus (GO:0009595) | 2.71657298 |
| 92 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.71506989 |
| 93 | positive regulation of B cell mediated immunity (GO:0002714) | 2.71506989 |
| 94 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.71315226 |
| 95 | regulation of mononuclear cell migration (GO:0071675) | 2.69941073 |
| 96 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.68578447 |
| 97 | regulation of interferon-alpha production (GO:0032647) | 2.68207414 |
| 98 | regulation of macrophage chemotaxis (GO:0010758) | 2.67883864 |
| 99 | peripheral nervous system neuron development (GO:0048935) | 2.67286777 |
| 100 | amyloid precursor protein catabolic process (GO:0042987) | 2.67045405 |
| 101 | negative regulation of bone remodeling (GO:0046851) | 2.66865549 |
| 102 | regulation of gamma-delta T cell activation (GO:0046643) | 2.66856573 |
| 103 | response to peptidoglycan (GO:0032494) | 2.66754132 |
| 104 | positive regulation of type 2 immune response (GO:0002830) | 2.64408143 |
| 105 | T-helper 1 type immune response (GO:0042088) | 2.64288275 |
| 106 | tolerance induction (GO:0002507) | 2.63917669 |
| 107 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.63491242 |
| 108 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.62968100 |
| 109 | regulation of interleukin-17 production (GO:0032660) | 2.62533398 |
| 110 | negative regulation of T cell mediated immunity (GO:0002710) | 2.62373868 |
| 111 | T cell costimulation (GO:0031295) | 2.62075055 |
| 112 | type I interferon signaling pathway (GO:0060337) | 2.61926455 |
| 113 | cellular response to type I interferon (GO:0071357) | 2.61926455 |
| 114 | response to type I interferon (GO:0034340) | 2.61921338 |
| 115 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.61665139 |
| 116 | neutrophil activation (GO:0042119) | 2.61128595 |
| 117 | thrombin receptor signaling pathway (GO:0070493) | 2.59747415 |
| 118 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.59108834 |
| 119 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.59051353 |
| 120 | leukocyte degranulation (GO:0043299) | 2.58987035 |
| 121 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.58462979 |
| 122 | dendritic cell chemotaxis (GO:0002407) | 2.58419033 |
| 123 | respiratory burst (GO:0045730) | 2.57817582 |
| 124 | lymphocyte costimulation (GO:0031294) | 2.57803184 |
| 125 | peptide catabolic process (GO:0043171) | 2.57739892 |
| 126 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.57045962 |
| 127 | positive regulation of leukocyte degranulation (GO:0043302) | 2.55725783 |
| 128 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.55697975 |
| 129 | regulation of tolerance induction (GO:0002643) | 2.55290351 |
| 130 | myeloid leukocyte activation (GO:0002274) | 2.54316457 |
| 131 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.51808762 |
| 132 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.50771482 |
| 133 | mast cell activation involved in immune response (GO:0002279) | 2.49873065 |
| 134 | mast cell degranulation (GO:0043303) | 2.49873065 |
| 135 | negative regulation of B cell proliferation (GO:0030889) | 2.48196911 |
| 136 | negative regulation of tissue remodeling (GO:0034104) | 2.46475530 |
| 137 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.46328677 |
| 138 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.45794805 |
| 139 | granulocyte activation (GO:0036230) | 2.44772251 |
| 140 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.44306474 |
| 141 | regulation of antigen processing and presentation (GO:0002577) | 2.44169036 |
| 142 | regulation of beta-amyloid formation (GO:1902003) | 2.42988179 |
| 143 | thymic T cell selection (GO:0045061) | 2.42741831 |
| 144 | T cell selection (GO:0045058) | 2.42032181 |
| 145 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.42018513 |
| 146 | negative regulation of interleukin-6 production (GO:0032715) | 2.41531508 |
| 147 | regulation of neutrophil migration (GO:1902622) | 2.39996344 |
| 148 | regulation of neutrophil chemotaxis (GO:0090022) | 2.39996344 |
| 149 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.39008434 |
| 150 | monocyte chemotaxis (GO:0002548) | 2.38701478 |
| 151 | positive regulation of isotype switching (GO:0045830) | 2.38080598 |
| 152 | lipoxygenase pathway (GO:0019372) | 2.36229731 |
| 153 | response to lipoprotein particle (GO:0055094) | 2.35743169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.06544669 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.59977558 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.21684185 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.68039404 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.48748138 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.41642739 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.33390308 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.86421954 |
| 9 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.69147454 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.60278373 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.55421741 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.47398380 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.47267158 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.17706459 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15361494 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.91221931 |
| 17 | SPI1_23127762_ChIP-Seq_K562_Human | 1.89145435 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.80656943 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.78570681 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.77777660 |
| 21 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.75746704 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74395758 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.71920075 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.65788744 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64344197 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62036493 |
| 27 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.59370409 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54035447 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53152204 |
| 30 | GATA1_19941826_ChIP-Seq_K562_Human | 1.52909182 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.49635057 |
| 32 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48792400 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45753537 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42428414 |
| 35 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42021819 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.39360729 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.36890986 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.36353136 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35134321 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.34591610 |
| 41 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33630525 |
| 42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32887452 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29258134 |
| 44 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25870732 |
| 45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24804278 |
| 46 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.23292263 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22454357 |
| 48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.22293065 |
| 49 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.21026965 |
| 50 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19852336 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17052343 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15409142 |
| 53 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.14997230 |
| 54 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11140256 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09984833 |
| 56 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.08967329 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08638418 |
| 58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05119576 |
| 59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05103472 |
| 60 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04934830 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.03033264 |
| 62 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01939440 |
| 63 | MYB_26560356_Chip-Seq_TH1_Human | 1.01811926 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00503948 |
| 65 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99812966 |
| 66 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99392584 |
| 67 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97263403 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96877829 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96873823 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95606215 |
| 71 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95025117 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94181551 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92247083 |
| 74 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.91383407 |
| 75 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90315477 |
| 76 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.89774682 |
| 77 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.88952398 |
| 78 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88487873 |
| 79 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87982074 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87753131 |
| 81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87023913 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86284705 |
| 83 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86196983 |
| 84 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86123392 |
| 85 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.85182732 |
| 86 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.84289648 |
| 87 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.84092594 |
| 88 | AR_25329375_ChIP-Seq_VCAP_Human | 0.84012381 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83746841 |
| 90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83746841 |
| 91 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83681025 |
| 92 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.83268176 |
| 93 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82980924 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82795556 |
| 95 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.82627207 |
| 96 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82203752 |
| 97 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81858138 |
| 98 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.81692068 |
| 99 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.81250163 |
| 100 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81237134 |
| 101 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81130950 |
| 102 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.81119317 |
| 103 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.81055765 |
| 104 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.80210281 |
| 105 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79668292 |
| 106 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79416602 |
| 107 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.79143798 |
| 108 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79121112 |
| 109 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.79046608 |
| 110 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.78762152 |
| 111 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.78595183 |
| 112 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78564045 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78454933 |
| 114 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.77499615 |
| 115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75892594 |
| 116 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.75579856 |
| 117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.75246401 |
| 118 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.75010243 |
| 119 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73662661 |
| 120 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.73652800 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72276801 |
| 122 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.69280582 |
| 123 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66770835 |
| 124 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.65565959 |
| 125 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.65531492 |
| 126 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.64173339 |
| 127 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.63515626 |
| 128 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.62312020 |
| 129 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.62071871 |
| 130 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.61948519 |
| 131 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.61828190 |
| 132 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.61279149 |
| 133 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.60162653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.40994762 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.03747012 |
| 3 | MP0005671_abnormal_response_to | 3.09326405 |
| 4 | MP0006082_CNS_inflammation | 3.07689549 |
| 5 | MP0002419_abnormal_innate_immunity | 2.59112869 |
| 6 | MP0002735_abnormal_chemical_nociception | 2.54508340 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.53363923 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.51758821 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.47326021 |
| 10 | MP0008004_abnormal_stomach_pH | 2.46915891 |
| 11 | MP0000015_abnormal_ear_pigmentation | 2.34423937 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.32154022 |
| 13 | MP0009840_abnormal_foam_cell | 2.29338739 |
| 14 | MP0001986_abnormal_taste_sensitivity | 2.27787373 |
| 15 | MP0000920_abnormal_myelination | 2.24849707 |
| 16 | MP0001800_abnormal_humoral_immune | 2.22070134 |
| 17 | MP0003690_abnormal_glial_cell | 2.21642548 |
| 18 | MP0005387_immune_system_phenotype | 2.18768441 |
| 19 | MP0001790_abnormal_immune_system | 2.18768441 |
| 20 | MP0002723_abnormal_immune_serum | 2.14013660 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.11003627 |
| 22 | MP0003183_abnormal_peptide_metabolism | 2.10401156 |
| 23 | MP0005025_abnormal_response_to | 2.08908602 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.05411367 |
| 25 | MP0009785_altered_susceptibility_to | 2.03613519 |
| 26 | MP0000685_abnormal_immune_system | 2.01092615 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.98192510 |
| 28 | MP0002405_respiratory_system_inflammati | 1.97910197 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.94017076 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.93921847 |
| 31 | MP0004510_myositis | 1.93090397 |
| 32 | MP0001819_abnormal_immune_cell | 1.92102862 |
| 33 | MP0003724_increased_susceptibility_to | 1.92005037 |
| 34 | MP0000604_amyloidosis | 1.88803190 |
| 35 | MP0005409_darkened_coat_color | 1.83831542 |
| 36 | MP0003436_decreased_susceptibility_to | 1.79385917 |
| 37 | MP0005174_abnormal_tail_pigmentation | 1.77750340 |
| 38 | MP0002736_abnormal_nociception_after | 1.76204730 |
| 39 | MP0005167_abnormal_blood-brain_barrier | 1.72294904 |
| 40 | MP0001968_abnormal_touch/_nociception | 1.71869475 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.71513256 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.71287665 |
| 43 | MP0005310_abnormal_salivary_gland | 1.65322370 |
| 44 | MP0003828_pulmonary_edema | 1.58460186 |
| 45 | MP0003075_altered_response_to | 1.50960647 |
| 46 | MP0004947_skin_inflammation | 1.48861986 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.47539900 |
| 48 | MP0006054_spinal_hemorrhage | 1.45818760 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.44728480 |
| 50 | MP0001851_eye_inflammation | 1.42270738 |
| 51 | MP0000716_abnormal_immune_system | 1.41259261 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.36337494 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.35780216 |
| 54 | MP0001873_stomach_inflammation | 1.31209482 |
| 55 | MP0009278_abnormal_bone_marrow | 1.29580412 |
| 56 | MP0002398_abnormal_bone_marrow | 1.29555598 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.28134119 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.21877407 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.21094299 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.21094299 |
| 61 | MP0004147_increased_porphyrin_level | 1.20669381 |
| 62 | MP0001970_abnormal_pain_threshold | 1.18940805 |
| 63 | MP0002006_tumorigenesis | 1.18767339 |
| 64 | MP0004270_analgesia | 1.18563663 |
| 65 | MP0003634_abnormal_glial_cell | 1.16546065 |
| 66 | MP0005166_decreased_susceptibility_to | 1.15718691 |
| 67 | MP0002733_abnormal_thermal_nociception | 1.15444118 |
| 68 | MP0009763_increased_sensitivity_to | 1.14432690 |
| 69 | MP0003045_fibrosis | 1.13593474 |
| 70 | MP0009764_decreased_sensitivity_to | 1.12997828 |
| 71 | MP0001984_abnormal_olfaction | 1.12026321 |
| 72 | MP0002009_preneoplasia | 1.10434609 |
| 73 | MP0010155_abnormal_intestine_physiology | 1.09376648 |
| 74 | MP0000249_abnormal_blood_vessel | 1.08476934 |
| 75 | MP0008469_abnormal_protein_level | 1.05115787 |
| 76 | MP0002933_joint_inflammation | 1.04055977 |
| 77 | MP0003329_amyloid_beta_deposits | 1.03456779 |
| 78 | MP0003633_abnormal_nervous_system | 1.03188750 |
| 79 | MP0005164_abnormal_response_to | 1.02788995 |
| 80 | MP0003279_aneurysm | 1.02538983 |
| 81 | MP0002429_abnormal_blood_cell | 1.02387544 |
| 82 | MP0002722_abnormal_immune_system | 1.00691965 |
| 83 | MP0004381_abnormal_hair_follicle | 1.00327435 |
| 84 | MP0001853_heart_inflammation | 0.97143868 |
| 85 | MP0004858_abnormal_nervous_system | 0.94608498 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 0.94270696 |
| 87 | MP0008260_abnormal_autophagy | 0.94028307 |
| 88 | MP0002095_abnormal_skin_pigmentation | 0.93238765 |
| 89 | MP0000372_irregular_coat_pigmentation | 0.91753833 |
| 90 | MP0005275_abnormal_skin_tensile | 0.91715526 |
| 91 | MP0006276_abnormal_autonomic_nervous | 0.90285115 |
| 92 | MP0005165_increased_susceptibility_to | 0.90121059 |
| 93 | MP0003448_altered_tumor_morphology | 0.89410119 |
| 94 | MP0000703_abnormal_thymus_morphology | 0.86052396 |
| 95 | MP0008874_decreased_physiological_sensi | 0.85603217 |
| 96 | MP0002396_abnormal_hematopoietic_system | 0.85453413 |
| 97 | MP0005390_skeleton_phenotype | 0.84795916 |
| 98 | MP0005595_abnormal_vascular_smooth | 0.82454628 |
| 99 | MP0004883_abnormal_blood_vessel | 0.82414964 |
| 100 | MP0003303_peritoneal_inflammation | 0.81818860 |
| 101 | MP0001542_abnormal_bone_strength | 0.81376696 |
| 102 | MP0000858_altered_metastatic_potential | 0.81112862 |
| 103 | MP0004130_abnormal_muscle_cell | 0.77998963 |
| 104 | MP0000343_altered_response_to | 0.77853643 |
| 105 | MP0005075_abnormal_melanosome_morpholog | 0.77731107 |
| 106 | MP0003091_abnormal_cell_migration | 0.77206570 |
| 107 | MP0000230_abnormal_systemic_arterial | 0.75870650 |
| 108 | MP0002229_neurodegeneration | 0.75734264 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.73982029 |
| 110 | MP0001663_abnormal_digestive_system | 0.73487123 |
| 111 | MP0002090_abnormal_vision | 0.73476242 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.73230018 |
| 113 | MP0002272_abnormal_nervous_system | 0.72924361 |
| 114 | MP0003631_nervous_system_phenotype | 0.70932408 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.69050120 |
| 116 | MP0005646_abnormal_pituitary_gland | 0.68269639 |
| 117 | MP0004742_abnormal_vestibular_system | 0.67973598 |
| 118 | MP0003866_abnormal_defecation | 0.67737547 |
| 119 | MP0005023_abnormal_wound_healing | 0.67129683 |
| 120 | MP0002067_abnormal_sensory_capabilities | 0.62779206 |
| 121 | MP0002139_abnormal_hepatobiliary_system | 0.62606793 |
| 122 | MP0008438_abnormal_cutaneous_collagen | 0.61356515 |
| 123 | MP0005647_abnormal_sex_gland | 0.61019456 |
| 124 | MP0003795_abnormal_bone_structure | 0.60418715 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.59561988 |
| 126 | MP0001905_abnormal_dopamine_level | 0.59508261 |
| 127 | MP0003656_abnormal_erythrocyte_physiolo | 0.59363063 |
| 128 | MP0008569_lethality_at_weaning | 0.58922450 |
| 129 | MP0002132_abnormal_respiratory_system | 0.58157880 |
| 130 | MP0004484_altered_response_of | 0.55637348 |
| 131 | MP0003638_abnormal_response/metabolism_ | 0.54971599 |
| 132 | MP0005535_abnormal_body_temperature | 0.54591086 |
| 133 | MP0005365_abnormal_bile_salt | 0.52006896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.59713957 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.12777117 |
| 3 | Glomerulonephritis (HP:0000099) | 4.88297183 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.83374086 |
| 5 | Prolonged bleeding time (HP:0003010) | 4.72493285 |
| 6 | Dysostosis multiplex (HP:0000943) | 4.68801729 |
| 7 | Petechiae (HP:0000967) | 4.55595627 |
| 8 | Purpura (HP:0000979) | 4.54389760 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.43634857 |
| 10 | Ulnar claw (HP:0001178) | 4.43041614 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 4.17407413 |
| 12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.15842102 |
| 13 | Epistaxis (HP:0000421) | 4.01659333 |
| 14 | Neurofibrillary tangles (HP:0002185) | 4.00744116 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.92455554 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.85059458 |
| 17 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.83273476 |
| 18 | Gingival bleeding (HP:0000225) | 3.71145999 |
| 19 | Stomatitis (HP:0010280) | 3.70788042 |
| 20 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.68683137 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.63087706 |
| 22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.63087706 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 3.63087706 |
| 24 | Complement deficiency (HP:0004431) | 3.52381433 |
| 25 | Axonal loss (HP:0003447) | 3.51312762 |
| 26 | Abnormal platelet volume (HP:0011876) | 3.48706387 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.38804177 |
| 28 | Thyroiditis (HP:0100646) | 3.31490731 |
| 29 | Increased mean platelet volume (HP:0011877) | 3.30779312 |
| 30 | Conjunctival telangiectasia (HP:0000524) | 3.26077506 |
| 31 | Myositis (HP:0100614) | 3.25601446 |
| 32 | Prostate neoplasm (HP:0100787) | 3.23396247 |
| 33 | Menorrhagia (HP:0000132) | 3.13745122 |
| 34 | Hypoplasia of the thymus (HP:0000778) | 3.12296035 |
| 35 | T lymphocytopenia (HP:0005403) | 3.12015400 |
| 36 | Supranuclear gaze palsy (HP:0000605) | 3.08813754 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.97332998 |
| 38 | Severe combined immunodeficiency (HP:0004430) | 2.93137988 |
| 39 | Abnormality of T cell number (HP:0011839) | 2.90556067 |
| 40 | Abnormality of complement system (HP:0005339) | 2.85501737 |
| 41 | Recurrent skin infections (HP:0001581) | 2.83383287 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 2.82967234 |
| 43 | Optic neuritis (HP:0100653) | 2.80350827 |
| 44 | Retrobulbar optic neuritis (HP:0100654) | 2.80350827 |
| 45 | Eosinophilia (HP:0001880) | 2.77781092 |
| 46 | Disinhibition (HP:0000734) | 2.77376435 |
| 47 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.74933028 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.74933028 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.74933028 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.71953036 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.71953036 |
| 52 | Agnosia (HP:0010524) | 2.70545381 |
| 53 | Panhypogammaglobulinemia (HP:0003139) | 2.70349986 |
| 54 | Recurrent fungal infections (HP:0002841) | 2.69617909 |
| 55 | Abnormality of B cell number (HP:0010975) | 2.64144375 |
| 56 | B lymphocytopenia (HP:0010976) | 2.64144375 |
| 57 | Basal ganglia calcification (HP:0002135) | 2.62611775 |
| 58 | Cerebral inclusion bodies (HP:0100314) | 2.62188693 |
| 59 | Hepatosplenomegaly (HP:0001433) | 2.61069761 |
| 60 | Encephalitis (HP:0002383) | 2.58798221 |
| 61 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.56478611 |
| 62 | Abnormal platelet function (HP:0011869) | 2.53985038 |
| 63 | Impaired platelet aggregation (HP:0003540) | 2.53985038 |
| 64 | Submucous cleft hard palate (HP:0000176) | 2.52224886 |
| 65 | Onion bulb formation (HP:0003383) | 2.51494493 |
| 66 | Hemoptysis (HP:0002105) | 2.51297107 |
| 67 | Abnormality of macrophages (HP:0004311) | 2.51141177 |
| 68 | Recurrent viral infections (HP:0004429) | 2.49024417 |
| 69 | Orchitis (HP:0100796) | 2.48739448 |
| 70 | Thick nail (HP:0001805) | 2.47413581 |
| 71 | Autoimmune hemolytic anemia (HP:0001890) | 2.47376093 |
| 72 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.45912423 |
| 73 | Nephritis (HP:0000123) | 2.44592036 |
| 74 | Mediastinal lymphadenopathy (HP:0100721) | 2.44360314 |
| 75 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.42836484 |
| 76 | Osteolytic defects of the hand bones (HP:0009699) | 2.42836484 |
| 77 | Increased IgM level (HP:0003496) | 2.42210001 |
| 78 | Abnormality of eosinophils (HP:0001879) | 2.37428525 |
| 79 | Leukocytosis (HP:0001974) | 2.36711238 |
| 80 | Peripheral demyelination (HP:0011096) | 2.36338423 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.32276350 |
| 82 | Gingivitis (HP:0000230) | 2.30142328 |
| 83 | Abnormality of T cells (HP:0002843) | 2.30003735 |
| 84 | Loss of speech (HP:0002371) | 2.29883189 |
| 85 | Action tremor (HP:0002345) | 2.27747607 |
| 86 | Abnormality of binocular vision (HP:0011514) | 2.27116412 |
| 87 | Diplopia (HP:0000651) | 2.27116412 |
| 88 | Chest pain (HP:0100749) | 2.26813896 |
| 89 | Pulmonary embolism (HP:0002204) | 2.24877422 |
| 90 | Pustule (HP:0200039) | 2.23292094 |
| 91 | Urticaria (HP:0001025) | 2.22319831 |
| 92 | Combined immunodeficiency (HP:0005387) | 2.20781656 |
| 93 | Colitis (HP:0002583) | 2.20271004 |
| 94 | Vasculitis (HP:0002633) | 2.20074076 |
| 95 | Abnormality of the prostate (HP:0008775) | 2.17792806 |
| 96 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17392288 |
| 97 | Obstructive lung disease (HP:0006536) | 2.17392288 |
| 98 | Joint swelling (HP:0001386) | 2.17162452 |
| 99 | Stomach cancer (HP:0012126) | 2.16458818 |
| 100 | Gastrointestinal inflammation (HP:0004386) | 2.16073565 |
| 101 | IgM deficiency (HP:0002850) | 2.10337569 |
| 102 | Hypothermia (HP:0002045) | 2.10130384 |
| 103 | Disproportionate tall stature (HP:0001519) | 2.09787018 |
| 104 | Mutism (HP:0002300) | 2.09142284 |
| 105 | Neuronal loss in central nervous system (HP:0002529) | 2.08898800 |
| 106 | Arterial thrombosis (HP:0004420) | 2.08408872 |
| 107 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.08206673 |
| 108 | Keratoconjunctivitis (HP:0001096) | 2.07861040 |
| 109 | Hematochezia (HP:0002573) | 2.06532787 |
| 110 | Polyneuropathy (HP:0001271) | 2.06378474 |
| 111 | Arterial tortuosity (HP:0005116) | 2.03010794 |
| 112 | Vertigo (HP:0002321) | 2.02251475 |
| 113 | Hypoproteinemia (HP:0003075) | 2.01943650 |
| 114 | Pulmonary infiltrates (HP:0002113) | 2.00756820 |
| 115 | Abnormality of iron homeostasis (HP:0011031) | 1.99437724 |
| 116 | J-shaped sella turcica (HP:0002680) | 1.98530218 |
| 117 | Chronic diarrhea (HP:0002028) | 1.96993152 |
| 118 | Peripheral hypomyelination (HP:0007182) | 1.96791469 |
| 119 | Apathy (HP:0000741) | 1.95504422 |
| 120 | Polycythemia (HP:0001901) | 1.95193330 |
| 121 | Slow saccadic eye movements (HP:0000514) | 1.95120336 |
| 122 | Increased serum ferritin (HP:0003281) | 1.94641427 |
| 123 | Mucosal telangiectasiae (HP:0100579) | 1.94320992 |
| 124 | Spontaneous hematomas (HP:0007420) | 1.94313610 |
| 125 | Granulocytopenia (HP:0001913) | 1.94055619 |
| 126 | Hyperlipoproteinemia (HP:0010980) | 1.93269828 |
| 127 | Gastrointestinal infarctions (HP:0005244) | 1.91510268 |
| 128 | Gangrene (HP:0100758) | 1.90357023 |
| 129 | Arthralgia (HP:0002829) | 1.90192477 |
| 130 | Abnormal hair whorl (HP:0010721) | 1.90029871 |
| 131 | Osteomyelitis (HP:0002754) | 1.88929294 |
| 132 | Meningitis (HP:0001287) | 1.88700550 |
| 133 | Periodontitis (HP:0000704) | 1.86361746 |
| 134 | Pathologic fracture (HP:0002756) | 1.86342602 |
| 135 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.84398775 |
| 136 | Recurrent cutaneous fungal infections (HP:0011370) | 1.84398775 |
| 137 | Progressive neurologic deterioration (HP:0002344) | 1.84201884 |
| 138 | Amyloidosis (HP:0011034) | 1.83048078 |
| 139 | Inflammation of the large intestine (HP:0002037) | 1.78706744 |
| 140 | Thoracic kyphosis (HP:0002942) | 1.78520694 |
| 141 | Episodic fever (HP:0001954) | 1.78253085 |
| 142 | Diminished motivation (HP:0000745) | 1.77277107 |
| 143 | Abnormality of the lumbar spine (HP:0100712) | 1.77173187 |
| 144 | Foot dorsiflexor weakness (HP:0009027) | 1.76663836 |
| 145 | Steppage gait (HP:0003376) | 1.75724909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.04492686 |
| 2 | TXK | 3.19138360 |
| 3 | GRK7 | 2.90420637 |
| 4 | BLK | 2.40348616 |
| 5 | RIPK4 | 2.32167658 |
| 6 | MAP3K14 | 2.27739377 |
| 7 | TYK2 | 2.22699576 |
| 8 | ITK | 2.21759642 |
| 9 | CSF1R | 2.15464120 |
| 10 | EPHB1 | 2.13670302 |
| 11 | MAP4K1 | 2.11156902 |
| 12 | IRAK4 | 2.00614208 |
| 13 | MAPKAPK5 | 1.85894111 |
| 14 | MAP3K13 | 1.83660883 |
| 15 | TBK1 | 1.74530261 |
| 16 | BMPR1B | 1.69892884 |
| 17 | JAK1 | 1.69802235 |
| 18 | IKBKE | 1.68650693 |
| 19 | ZAP70 | 1.67826177 |
| 20 | KIT | 1.63118738 |
| 21 | BMPR2 | 1.59272498 |
| 22 | MAP2K3 | 1.58474291 |
| 23 | NTRK1 | 1.57692630 |
| 24 | TRPM7 | 1.54803748 |
| 25 | GRK6 | 1.51247881 |
| 26 | LCK | 1.48310597 |
| 27 | CLK1 | 1.47846885 |
| 28 | ACVR1B | 1.47011807 |
| 29 | STK10 | 1.42921337 |
| 30 | IRAK3 | 1.37963933 |
| 31 | PRPF4B | 1.36900135 |
| 32 | FES | 1.31016297 |
| 33 | MAPK15 | 1.28229297 |
| 34 | MARK3 | 1.28225346 |
| 35 | HCK | 1.27934834 |
| 36 | STK39 | 1.26971829 |
| 37 | SYK | 1.24317788 |
| 38 | GRK5 | 1.24153384 |
| 39 | PIK3CG | 1.23884060 |
| 40 | TEC | 1.21302030 |
| 41 | IKBKB | 1.20105919 |
| 42 | MYLK | 1.18944670 |
| 43 | TAOK3 | 1.18222017 |
| 44 | ADRBK2 | 1.16361663 |
| 45 | BTK | 1.13607827 |
| 46 | MAP3K12 | 1.13142832 |
| 47 | WNK1 | 1.12798505 |
| 48 | CSK | 1.12082993 |
| 49 | YES1 | 1.11456175 |
| 50 | FGR | 1.10498483 |
| 51 | MAP3K2 | 1.09911130 |
| 52 | CAMKK2 | 1.09051736 |
| 53 | ERN1 | 1.05337209 |
| 54 | JAK3 | 1.04841561 |
| 55 | MOS | 1.04299294 |
| 56 | MAP3K3 | 1.02880941 |
| 57 | DDR2 | 0.98780974 |
| 58 | MAP3K1 | 0.94697398 |
| 59 | LYN | 0.94086639 |
| 60 | NEK9 | 0.92490884 |
| 61 | FGFR3 | 0.91428949 |
| 62 | TNK2 | 0.89060740 |
| 63 | JAK2 | 0.88898159 |
| 64 | MATK | 0.87364069 |
| 65 | PKN1 | 0.84692582 |
| 66 | BMX | 0.83887742 |
| 67 | SIK3 | 0.79529139 |
| 68 | MAP4K2 | 0.78091179 |
| 69 | TAOK2 | 0.77841735 |
| 70 | MAP3K11 | 0.77516302 |
| 71 | HIPK2 | 0.77295622 |
| 72 | PRKCQ | 0.76794401 |
| 73 | RET | 0.76442326 |
| 74 | FGFR4 | 0.76410320 |
| 75 | SIK2 | 0.75744168 |
| 76 | MINK1 | 0.74926387 |
| 77 | CAMK1G | 0.73300748 |
| 78 | CDK9 | 0.72162869 |
| 79 | PIM1 | 0.72005702 |
| 80 | PDPK1 | 0.71373104 |
| 81 | CAMK1D | 0.70553885 |
| 82 | CDC42BPA | 0.69580586 |
| 83 | RIPK1 | 0.67150002 |
| 84 | MAPKAPK2 | 0.66952023 |
| 85 | MAP3K5 | 0.66102468 |
| 86 | FGFR2 | 0.65406078 |
| 87 | MAPKAPK3 | 0.65258836 |
| 88 | SGK494 | 0.65109372 |
| 89 | SGK223 | 0.65109372 |
| 90 | SGK3 | 0.65077835 |
| 91 | MAP3K10 | 0.64447823 |
| 92 | PDGFRB | 0.63627168 |
| 93 | FYN | 0.63392506 |
| 94 | SGK2 | 0.62875697 |
| 95 | ARAF | 0.62046349 |
| 96 | PIM2 | 0.61409861 |
| 97 | MAPK7 | 0.60059701 |
| 98 | PDK2 | 0.60011224 |
| 99 | CDK3 | 0.59563841 |
| 100 | MARK2 | 0.58622106 |
| 101 | PDK1 | 0.57845035 |
| 102 | EPHA3 | 0.56976206 |
| 103 | LMTK2 | 0.56885172 |
| 104 | NLK | 0.56712971 |
| 105 | IGF1R | 0.53268840 |
| 106 | MAP2K2 | 0.53072974 |
| 107 | MAP2K7 | 0.53066009 |
| 108 | PTK2B | 0.52914069 |
| 109 | INSR | 0.51984100 |
| 110 | IRAK2 | 0.51307480 |
| 111 | EGFR | 0.51095436 |
| 112 | ABL1 | 0.50750021 |
| 113 | PRKCD | 0.49951169 |
| 114 | PHKG1 | 0.49778080 |
| 115 | PHKG2 | 0.49778080 |
| 116 | MST4 | 0.49362272 |
| 117 | TGFBR1 | 0.49059560 |
| 118 | KDR | 0.48857594 |
| 119 | CDK5 | 0.48727668 |
| 120 | ADRBK1 | 0.48079512 |
| 121 | CAMKK1 | 0.46516021 |
| 122 | PRKD1 | 0.46347876 |
| 123 | MAPK12 | 0.44588887 |
| 124 | CHUK | 0.42588352 |
| 125 | OXSR1 | 0.42497730 |
| 126 | SCYL2 | 0.42206759 |
| 127 | PRKCH | 0.41776663 |
| 128 | KSR2 | 0.41627212 |
| 129 | IRAK1 | 0.41070220 |
| 130 | CASK | 0.41062249 |
| 131 | MAP3K6 | 0.37403477 |
| 132 | MAPK4 | 0.36941471 |
| 133 | DAPK2 | 0.36463653 |
| 134 | TESK2 | 0.35514730 |
| 135 | CDK6 | 0.32244178 |
| 136 | DYRK1B | 0.28502305 |
| 137 | MAPK11 | 0.27601430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.04892414 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.60510939 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 2.49692682 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.23736775 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.22863163 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22436474 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.21653389 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.08788309 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.03732686 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.02598064 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 1.95076047 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.87633408 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.83638515 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.75410570 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.75389792 |
| 16 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.74672484 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.64835565 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.62934055 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.61134606 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.60199803 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.58387388 |
| 22 | Salmonella infection_Homo sapiens_hsa05132 | 1.53366295 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.49092149 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47643769 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46968051 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.46814756 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44760646 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.42251394 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39458243 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34078135 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.29268178 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.29147373 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13871345 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.12853243 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10571597 |
| 36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10141177 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08075515 |
| 38 | Endocytosis_Homo sapiens_hsa04144 | 1.07539869 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04446113 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99330547 |
| 41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.95615279 |
| 42 | Olfactory transduction_Homo sapiens_hsa04740 | 0.95332154 |
| 43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94376067 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93015363 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88814238 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.83591739 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 0.82197772 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 0.82181499 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79861943 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79804573 |
| 51 | Asthma_Homo sapiens_hsa05310 | 0.79693439 |
| 52 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78387338 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.77661557 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.76951482 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76739971 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.76314120 |
| 57 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74747713 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.74745305 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74309779 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73674102 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.71454936 |
| 62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69424332 |
| 63 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69283359 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68892847 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66742423 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66370380 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66321745 |
| 68 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.65319238 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65003075 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 0.64186327 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63967217 |
| 72 | Renin secretion_Homo sapiens_hsa04924 | 0.63145496 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59419283 |
| 74 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59314217 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58536254 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58358827 |
| 77 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.56756355 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55881284 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.55412981 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52712945 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51802365 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51416428 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51163175 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50444106 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50377663 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49616589 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.49191243 |
| 88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48256848 |
| 89 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.47777034 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47710541 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46194608 |
| 92 | Salivary secretion_Homo sapiens_hsa04970 | 0.45456909 |
| 93 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.45413750 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45119673 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44579922 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44040879 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43590478 |
| 98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43173990 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.43112230 |
| 100 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41287908 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41284857 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41027117 |
| 103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39251041 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37794491 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37382379 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36371644 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36180749 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35805943 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32192833 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30681763 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29664667 |
| 112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29475245 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28921599 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27587717 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.27360583 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.25145038 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23513424 |
| 118 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.22858756 |

